Jennifer Hu is currently the Associate Director of Vector and Drug Substance Analytics at GentiBio. Before that, Jennifer held various roles at Bristol Myers Squibb and worked as a Postdoctoral Researcher at Massachusetts Institute of Technology. Jennifer has a Ph.D. in Chemistry and Biological Engineering from MIT and a Bachelor of Science in Chemical Biology from UC Berkeley. Their extensive experience includes method development for high-throughout (t)RNA sequencing, NGS data processing, and analyzing tRNA modification and abundance signals in mycobacteria. Jennifer has also received awards for their teaching and research work.
June, 2022 - present